As a result, we observed that rs1799966 (BRCA1) was significantly associated with pancreatic cancer patients’ overall survival with HR being 1.24 under an additive model (95% CI: 1.09–1.40, P = 0.0010) (Table 2 and Figure 2). This evidence concerns the gene BRCA1 and pancreatic neoplasm.